Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dextera Surgical Inc (NASDAQ:DXTR)

Delayed Data
As of Jul 25
 -0.04 / -1.68%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Its technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. The company manufactures and markets automated anastomosis systems, the C-Port Distal Anastomosis systems and PAS-Port Proximal Anastomosis system for coronary artery bypass graft surgery. Its product MicroCutter is used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Redwood City, CA.

Contact Information

Dextera Surgical, Inc.
900 Saginaw Drive
Redwood City California 94063
P:(650) 364-9975
Investor Relations:
(650) 331-7133



Mutual fund holders9.64%
Other institutional30.06%
Individual stakeholders--

Top Executives

Julian N. NikolchevPresident, Chief Executive Officer & Director
Thomas J. PalermoChief Operating Officer
Robert Y. NewellCFO, Secretary, VP-Finance & Head-Media Relations
Gregory Paul WatsonVice President-Operations
Liam BurnsVice President-Sales & Marketing